Blame bad incentives for bad science
By Bethany Berkshire,
ScienceNews
| 10. 21. 2016
Most of us spend our careers trying to meet — and hopefully exceed — expectations. Scientists do too. But the requirements for success in a job in academic science don’t always line up with the best scientific methods. The net result? Bad science doesn’t just happen — it gets selected for.
What does it mean to be successful in science? A scientist gets a job and funding by publishing a lot of high-impact papers with novel findings. Those papers and findings beget awards and funding to do more science — and publish more papers. “The problem that we face is that the incentive system is focused almost entirely on getting research published, rather than on getting research right,” says Brian Nosek, a psychologist at the University of Virginia in Charlottesville.
This idea of success has become so ingrained that scientists are even introduced when they give talks by the number of papers they have published or the amount of grant funding they have, says Marc Edwards, a civil engineer at Virginia Polytechnic Institute and State University in Blacksburg.
But rewarding...
Related Articles
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ewan Bolton, The Telegraph | 11.12.2024
Fertility agencies offering embryo selection for IVF and surrogacy have been accused of promoting eugenics and misleading consumers about the power of genetic screening.
Some American clinics claim they can “rank” embryos for IVF using Preimplantation Genetic Testing for Polygenic...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...
By Fyodor Urnov, The CRIPSR Journal | 10.18.2024
The field of clinical gene editing has a bona fide crisis on its hands—a crisis that has to, and can be, promptly resolved.
An outside observer of our field might be surprised by this and say—what crisis? The first...